Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype

Journal of Immunology

Volumn 162, Issue 6, 1999, Pages 3702-3710

  Claesson, Mogens H ^a,d   Bregenholt, Søren ^a   Bonhagen, Kerstin ^b   Thoma, Stefan ^b   Möller, Peter ^b   Grusby, Michael J ^c   Leithäuser, Frank ^b   Nissen, Mogens H ^a   Reimann, Jörg ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF ULM   (Germany)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HISTOPATHOLOGY; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; DNA-BINDING PROTEINS; FEMALE; IMMUNOPHENOTYPING; INFLAMMATORY BOWEL DISEASES; INTERFERON TYPE II; INTERLEUKIN-12; INTERPHASE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, SCID; SEVERE COMBINED IMMUNODEFICIENCY; SIGNAL TRANSDUCTION; STAT4 TRANSCRIPTION FACTOR; TH1 CELLS; TRANS-ACTIVATORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033559891     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Podolsky, D. K. 1991. Inflammatory bowel disease. N. Engl. J. Med. 325:928.
2. Grisham, M. 1993. Animal models of inflammatory bowel disease. Curr. Opin. Gastroenterol. 9:524.
3. Bhan, A. K., E. Mizoguchi, and A. Mizoguchi. 1994. New models of chronic intestinal inflammation. Curr. Opin. Gastroenterol. 10:633.
4. Conner, E. M., S. Aiko, and M. Grisham. 1994. Genetically engineered models of inflammatory bowel disease. Curr. Opin. Gastroenterol. 10:358.
5. MacDermott, R. P. 1994. Inflammatory bowel Disease. Curr. Opin. Gastroenterol. 10:355.
6. Powrie, F. 1995. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 3:171.
7. Fiocchi, C. 1993. Cytokines and animal models: a combined path to inflammatory bowel disease pathogenesis. Gastroenterology 104:1202.
8. Herfarth, H. H., and R. B. Sartor. 1994. Cytokine regulation of experimental intestinal inflammation. Curr. Opin. Gastroenterol. 10:625.
9. Sartor, R. B. 1994. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 106:533.
10. Neurath, M. F., and B. K. Meyer-zum. 1996. Protective and pathogenic roles of cytokines in inflammatory bowel diseases. J. Invest. Med. 44:516.
11. low subset. J. Exp. Med. 172:1701.
12. + T cells and their roles in the induction and prevention of autoimmunity. Immunol. Rev. 123:37.
13. + T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177:627.
14. lo T cells. Res. Immunol. 145:357.
15. + T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int. Immunol. 5:1461.
16. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179:589.
17. + T cells. J. Exp. Med. 178: 237.
18. hi T cells. Immunity 1:553.
19. + T cells. Am. J. Pathol. 148:1503.
20. high T cells to SCID recipients. J. Immunol. 158:3464.
21. + T cells in the pathogenesis of murine inflammatory bowel disease. Eur. J. Immunol. 24:2803.
22. + T cell population in severe-combined immunodeficient mice expressing a rearranged, transgenic class 1-restricted αβ T cell receptor. Eur. J. Immunol. 25:1643.
23. + αβ T cells in SCID mice with colitis. Eur. J. Immunol. 26:3074.
24. + T lymphocytes injected into scid mice lead to an inflammatory and lethal bowel disease. Clin. Exp. Immunol. 104:491.
25. + αβ T cells in the colonic lamina propria of scid mice with colitis. Eur. J. Immunol. 26:1156.
26. + TCR αβ T cells of athymic origin in histocompatible severe combined immunodeficient (SCID) mice. Clin. Exp. Immunol. 112:443.
27. + T cells from scid mice with inflammatory bowel disease. Eur. J. Immunol. 28:3655.
28. Bregenholt, S., and M. H. Claesson. 1998. Increased intracellular Th1 cytokines in scid mice with inflammatory bowel disease. Eur. J. Immunol. 28:379.
29. + T cells repopulating SCID mice with colitis. Eur. J. Immunol. 28:1785.
30. + T cells from IFN-γ knockout mice do not induce wasting disease. J. Autoimmun. 10:455.
31. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulalory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
32. Leonard, W. J., and J. J. O'Shea. 1998. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16:293.
33. Gately, M. K., L. M. Renzetti, J. Magram, A. S. Stern, L. Adorini, U. Gubler, and D. H. Presky. 1998. Interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol 16:495.
34. Kaplan, M. H., Y.L. Sun, T. Hoey, and M. J. Grusby. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174.
35. Boll, G., and J. Reimann. 1995. Lamina propria T cell subsets in the small and large intestine of euthymic and athymic mice. Scand. J. Immunol. 42:191.
36. + lamina propria T-cell lines: phenotypic and functional characterization. Immunology 75:66.
37. Nissen, M. H., S. Bregenholt, J. A. Nording, and M. H. Claesson. 1998. Clesterase inhibitor blocks T lymphocyte proliferation and cytotoxic T lymphocyte generation in vitro. Int. Immunol. 10:167.
38. + TH1-like responses. J. Clin. Invest. 98:1010.
39. Neurath, M. F., I. Fuss, B. L. Kelsall, B. K. Meyer-zum, and W. Strober. 1996. Effect of IL-12 and anybodies to IL-12 on established granulomatous colitis in mice. Ann. NY Acad. Sci. 795:368.
40. + T cells. J. Exp. Med. 183:2669.
41. Stuber, H., W. Strober, and M. F. Neurath. 1996. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med 183:693.
42. Ehrhardt, R. O., B. R. Ludviksson, B. Gray, M. F. Neurath, and W. Strober. 1997. Induction and prevention of colonic inflammation in IL-2-deficient mice. J. Immunol. 158:566.
43. + T cells and proinflammatory Th1-type cytokines. J. Immunol. 158:1068.
44. Ludviksson, B. R., B. Gray, W. Strober, and R. O. Ehrhardt. 1997. Dysregulated intrathymic development in the IL-2-deficient mouse leads to colitis-inducing thymocytes. J. Immunol. 158:104.
45. - T cells in an experimental model of colitis. Eur. J. Immunol. 27:17.
46. Hermiston, M. L., and J. I. Gordon. 1995. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270:1203.
47. Hollander, G. A., S. J. Simpson, E. Mizoguchi, A. Nichogiannopoulou, J. She, J. C. Gutierrez Ramos, A. K. Bhan, S. J. Burakoff, B. Wang, and C. Terhorst. 1995. Severe colitis in mice with aberrant thymic selection. Immunity 3:27.
48. Rennick, D., N. Davidson, and D. J. Berg. 1995. Interleukin-10 gene knock-out mice: a model of chronic inflammation. Clin. Immunol. Immunopathol. 76:S174.
49. Rudolph, U., M. J. Finegold, S. S. Rich, G. R. Harriman, Y. Srinivasan, P. Brabet, A. Bradley, and L. Birnbaumer. 1995. Gai2 protein deficiency: a model of inflammatory bowel disease. J. Clin. Immunol. 15:101S.
50. Rudolph, U., M. J. Finegoid, S. S. Rich, G. R. Harriman, Y. Srinivasan, P. Brabet, G. Boulay, A. Bradley, and L. Birnbaumer. 1995. Ulcerative colitis and adenocarcinoma of the colon in Gai2-deficient mice. Nat. Genet. 10:143
51. + T cells. Eur. J. Immunol. 25:3053.
52. + T cells are responsible for murine interleukin-2-deficient colitis. Eur. J. Immunol. 25:2618.
53. McCall, R. D., S. Haskill, E. M. Zimmermann, P. K. Lund, R. C. Thompson, and R. B. Sartor. 1994. Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. Gastroenterology 106:960.
54. Kühn, R., J. Löhler, D. Rennick, K. Rajewsky, and W. Möller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263.
55. Mombaerts, P., E. Mizoguchi, M. J. Grusby, L. H. Glimcher, A. K. Bhan, and S. Tonegawa. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75:275.
56. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A. C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253.
57. Taurog, J. D., S. D. Maika, W. A. Simmons, M. A. Breban, and R. E. Hammer. 1993. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J. Immunol. 150:4168.
58. Neurath, M. F., I. Fuss, B. L. Kelsall, D. H. Presky, W. Waegell, and W. Strober. 1996. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J. Exp. Med. 183:2605.
59. + T cells. J. Immunol. 158:2099.
60. + T cells migrating into the murine small intestine epithelial layer. Eur. J. Immunol. 25:1580.
61. MacDonald, T. T., and J. Spencer. 1988. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J. Exp. Med. 167:1346.
62. Bregenholt, S., and M. H. Claesson. 1998. Splenic T helper cell type I cytokine profile and extramedullary haematopoiesis in severe combined immunodeficient (scid) mice with inflammatory bowel disease (IBD). Clin. Exp. Immunol. 111: 166.
63. Neurath, M. F., I. Fuss, M. Pasparakis, L. Alexopoulou, S. Haralambous, B. K. Meyer-zum, W. Strober, and G. Kollias. 1997. Predominant pathogenic role ouf tumor necrosis factor in experimental colitis in mice. Eur. J. Immunol. 27: 1743.
64. Barbulescu, K., C. Becker, J. F. Schlaak, E. Schmmitt, K.-H. Meyer zum Buschenfelde, and M. F. Neurath. 1998. IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-g promoter in primary CD4+ T lymphocytes. J. Immunol. 160:3642.
65. Simpson, S. J., S. Shah, M. Comiskey, J. Y. de, B. Wang, E. Mizoguchi, A. K. Bhan, and C. Terhorst. 1998. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J. Exp. Med. 187:1225.